Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.93M Buy
73,585
+1,547
+2% +$148K 0.27% 72
2026
Q2
$6.1M Buy
72,038
+69,983
+3,405% +$5.64M 0.25% 88
2026
Q1
$145K Sell
2,055
-210
-9% -$15.7K 0.01% 981
2025
Q4
$179K Buy
2,265
+97
+4% +$7.68K 0.01% 905
2025
Q3
$179K Buy
2,168
+1
+0% +$79 0.01% 715
2025
Q2
$174K Sell
2,167
-92
-4% -$7.1K 0.01% 684
2025
Q1
$181K Sell
2,259
-51
-2% -$4.24K 0.02% 645
2024
Q4
$189K Buy
2,310
+20
+0.9% +$1.66K 0.02% 639
2024
Q3
$189K Buy
+2,290
New +$171K 0.02% 633

Other funds holding MET

BFC Planning's MET Position: Q3 2026 in Review

BFC Planning increased its MetLife (MET) stake by 2.1% in Q3 2026, buying an estimated $148K and bringing the position to 73,585 shares worth $6.93M. The position accounts for 0.27% of the portfolio, ranked #72.

BFC Planning first reported a position in MET in Q3 2024 and has held it in 9 quarters since. 1,309 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • BFC Planning held 73,585 shares of MetLife worth $6.93M as of Q3 2026.
  • BFC Planning bought 1,547 MetLife shares in Q3 2026, an estimated $148K.
  • MetLife made up 0.27% of BFC Planning's portfolio in Q3 2026, its #72 holding.
  • BFC Planning first reported a position in MetLife in Q3 2024 and has held it in 9 quarters since.
  • 1,309 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.